Vitrolife AB (VITR.ST)

Nasdaq Stockholm · Financial statements, TTM figures and earnings dates

In fiscal year 2024 (ended December 31, 2024), Vitrolife AB reported revenue of SEK 3.61B and net income of SEK 513.0M. Annual financial statements are available for fiscal years 2020 to 2024, taken from the company's ESEF annual reports (IFRS).

Open interactive financials →

Key financials

SEK	FY2024 2024-12-31	FY2023 2023-12-31	FY2022 2022-12-31	FY2021 2021-12-31	FY2020 2020-12-31
Income statement
Revenue	SEK 3.61B	SEK 3.51B	SEK 3.23B	SEK 1.68B	SEK 1.25B
Gross profit	SEK 2.14B	SEK 1.98B	SEK 1.78B	SEK 1.05B	SEK 767.7M
Operating income	SEK 783.0M	−SEK 3.59B	SEK 654.0M	SEK 435.0M	SEK 370.0M
Net income	SEK 513.0M	−SEK 3.85B	SEK 394.0M	SEK 341.0M	SEK 286.8M
Diluted EPS	SEK 3.78	−SEK 28.44	SEK 0.03	SEK 2.97	SEK 2.64
Cash flow
Operating cash flow	SEK 907.0M	SEK 757.0M	SEK 636.0M	SEK 384.0M	SEK 356.4M
Capital expenditure	SEK 92.0M	SEK 67.0M	SEK 51.0M	SEK 25.0M	SEK 6.8M
Free cash flow	SEK 815.0M	SEK 690.0M	SEK 585.0M	SEK 359.0M	SEK 349.7M
Balance sheet
Cash and equivalents	SEK 1.14B	SEK 861.0M	SEK 578.0M	SEK 630.0M	SEK 974.0M
Total assets	SEK 17.45B	SEK 16.33B	SEK 20.55B	SEK 19.43B	SEK 2.31B
Total liabilities	SEK 3.81B	SEK 3.61B	SEK 3.81B	SEK 4.09B	SEK 288.1M
Total debt	SEK 1.84B	SEK 1.88B	SEK 1.99B	SEK 1.94B	SEK 0
Shareholders' equity	SEK 13.64B	SEK 12.72B	SEK 16.74B	SEK 15.32B	SEK 2.01B

TTM = trailing twelve months (balance-sheet items at the latest quarter end). Figures in SEK as reported; per-share data adjusted for stock splits.

Annual reports

More on the interactive page

The full VITR.ST page on Aurora Financial Journal includes every fiscal year since the company began filing structured data, income statement, balance sheet and cash flow statement line by line, charts for every measure, valuation multiples (P/E, P/S, P/B), live price charts and the earnings calendar.

Open VITR.ST financials →